News

Digital Diabetes Care Has a Bigger Prize Than Devices

Digital Diabetes Care Has a Bigger Prize Than Devices

A glucose sensor is becoming less a gadget than a running conversation between patient, clinician and software. That shift matters because diabetes management is leaving the occasional clinic visit and moving into daily life, where the useful product is not merely a reading but a pattern someone can act on. The sector deserves attention from investors, but it also deserves some restraint: this is healthcare, not a scoreboard for shiny hardware.

The Market Estimate Has Real Weight

Wissen Research puts the global digital diabetes management market at $20.9 billion in 2026 and projects $34.4 billion by 2031, a 10.5% compound annual growth rate. Forecasts are forecasts, not promissory notes, and plenty of market studies carry more confidence than precision. Still, the direction is hard to dismiss when the underlying patient population is so large. The International Diabetes Federation estimates 589 million adults lived with diabetes in 2024 and expects 853 million by 2050.

That is a grim public-health backdrop, not a cheerleading statistic. Yet it explains why continuous glucose monitoring, connected pumps, smart pens and data platforms have become strategically important. The commercial prize is recurring sensor and disposable demand, plus the possibility that software and data services make a device ecosystem harder to leave.

Type 2 Is Where the Argument Gets Serious

For years, the most sophisticated connected tools were largely built around Type 1 diabetes. The much bigger opening is Type 2, particularly insulin-treated people and, increasingly, people who do not use insulin. FDA actions in 2024 cleared Dexcom's Stelo and Abbott's Lingo for over-the-counter use, while Abbott's Libre Rio was cleared for adults with Type 2 diabetes not using insulin. In June 2026, Stelo's clearance was extended to children aged two and older who do not use insulin.

The clinical rationale is encouraging but should not be oversold. A 2025 randomized trial involving 72 adults with Type 2 diabetes who were not taking insulin found CGM users improved time-in-range from 46% to 72% over six months and reduced HbA1c by 1.3 percentage points. That is meaningful. It is also a small study, and larger confirmation matters before anybody starts treating one result as the whole case.

Integration Is Becoming the Product

The old device-by-device view is getting stale. Remote diabetes data uploads surpassed in-clinic uploads in early 2024 and were roughly 1.5 times higher by year-end, according to Glooko's 2025 report. Patients and care teams increasingly need sensor data, insulin delivery and coaching tools to cooperate without making the user play unpaid systems integrator.

That is why interoperability has genuine business significance. Tandem Diabetes Care received Health Canada approvals in November 2026 for its t:slim X2 pump with Control-IQ+ technology, including compatibility with Abbott's FreeStyle Libre 3 Plus sensor. Commercial availability is expected in the second quarter of 2027. Medtronic's MiniMed Go pairs its InPen smart pen with Abbott's Instinct sensor, while Insulet has been pushing Omnipod Discover, a web-based data platform for Omnipod 5 users, caregivers and clinicians.

Each announcement sounds incremental in isolation. Together, they show a market moving toward ecosystems. Abbott's multi-year partnership with Google Health, announced in August 2026, similarly aims to combine Lingo glucose insights with AI-powered health technology. The opportunity is obvious; so are the privacy, cybersecurity and evidence questions around turning health data into advice.

Recurring Revenue Meets a Hard Affordability Wall

Devices led the market in 2025, supported by the repeat purchase cycle for sensors and other consumables. Abbott reported $7.6 billion in CGM sales that year, Dexcom reported $4.66 billion in revenue, up 16%, and Insulet reported $2.67 billion in Omnipod revenue, up 31.6%. Those are serious numbers, not a niche wellness fad.

But diabetes technology has an ugly access problem. A 2025 study across six low- and middle-income countries found sensors cost roughly $88 to $107 each, with a month's supply requiring 15 to 65 days of wages. Medicare coverage in the United States also remains tied to insulin treatment or documented problematic hypoglycemia. A market can grow briskly and still leave a great many people out; both things can be true at once.

  • Watch reimbursement expansion, because coverage often determines adoption more than product polish.
  • Watch manufacturing quality and regulatory compliance as over-the-counter CGM reaches a broader public.
  • Watch whether software reduces clinical workload rather than simply adding another dashboard.

Scale Will Not Automatically Pick the Winners

North America remains the leading region, while Asia Pacific is identified as the fastest-growing. The long runway in Asia is compelling: the Western Pacific had about 215.4 million adults with diabetes in 2024, and South-East Asia had another 106.9 million. But broad need does not magically solve pricing, connectivity, local reimbursement or digital literacy.

The durable winners should be the companies that make accurate monitoring affordable, connect cleanly with other systems and prove that the information improves care. Fancy algorithms are fine. Dependable access is better. In this corner of medtech, trust gets built one sensor, one reimbursement decision and one workable patient experience at a time.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 64

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
U.S. Employers Signal a Deeper Multilingual Skills Gap

Updated Category News Views 15

A language gap rarely makes the loudest noise in an earnings call, yet it can quietly wreck a sales effort, a hiring plan, or a customer relationship. ACTFL's updated 2026 employer study puts some hard edges around that problem: U.S. businesses say multilingual capability is not a nice cultural accessory. It is increasingly part of operating the business. Demand Has Moved...

Continue Reading
New York's $1.2M Prison Abuse Deal Raises State Stakes

Updated Category News Views 41

One courtroom result can expose a whole warehouse of institutional neglect, and this one lands with a grim thud. New York has agreed to pay $1.2 million to resolve a claim involving sexual assault by a former corrections officer at Bayview Correctional Facility in Manhattan. The settlement came after a two-week Adult Survivors Act bellwether trial concluded on November 17...

Continue Reading
MTI Adds Aviation Veterans as Acorn Builds MRO Plan

Updated Category News Views 95

Two old hands entering a boardroom can matter more than another glossy growth slogan, especially in aircraft maintenance, where a delayed part can ground an airplane and turn a customer relationship sour in a hurry. MTI Aviation has added Tony DiSimone Sr. and Aviv Tzur to its board, a move announced November 20, 2026, after Acorn Capital Management took a majority...

Continue Reading
Arizona's Dry Climate Puts Scalp Health Under Stress

Updated Category News Views 35

Desert weather is unforgiving, and apparently the scalp does not get a pass. In a Nov. 20, 2026 discussion, Scottsdale and Tucson hair-restoration physician Dr. Sharon A. Keene frames Arizona hair concerns around something easy to overlook: the condition of the skin beneath the hair. That is a more sensible starting point than treating every strand in the shower like it...

Continue Reading
PetSmart Charities Adds Strategy Role for Pet Families

Updated Category News Views 347

A pet bowl can become a crisis marker faster than people admit. Housing trouble, empty cupboards, a hurricane, or an unaffordable veterinary bill can turn a loved animal into one more impossible responsibility. That is the uncomfortable reality behind PetSmart Charities' decision to create a vice president of strategic programs and partnerships role and appoint Heather...

Continue Reading
Trump's Reagan Forum Speech Puts Defense in Focus Again

Updated Category News Views 10

A December podium in Simi Valley has suddenly become a market-relevant appointment. The Ronald Reagan Presidential Foundation and Institute says President Donald J. Trump will deliver the keynote at the 2026 Reagan National Defense Forum on Friday, December 4, at 3:00 p.m. Pacific time, or 6:00 p.m. Eastern. That is the whole hard fact pattern so far. No agenda, no...

Continue Reading
Melio’s AP Push Looks Useful, but Read the Fine Print

Updated Category News Views 87

Back-office drudgery rarely gets anyone’s pulse racing, yet it can quietly chew through a small business’s time and cash. That is why Melio’s latest recognition as Software Experts’ top pick for accounts payable automation deserves a look. The product pitch is straightforward: pull bills, approvals, payments and reconciliation into one workflow rather than leaving...

Continue Reading
Duetti, CesiumAstro, and a Busy NYSE Capital Morning

Updated Category News Views 73

Three very different piles of money are jamming up the November 20 NYSE slate, and that contrast is the whole point. Private music catalogs, space-and-defense communications, and a new stock-and-bond ETF do not belong in the same bucket. Yet all three are competing for investor attention before the opening bell, alongside Danaos Corporation's 20th listing anniversary....

Continue Reading
Hope Charities Makes Care Funding Easier to Track Online

Updated Category News Views 72

A treatment bill can wreck a household long before a diagnosis does. That is the uncomfortable reality behind Hope Charities' new Access to Care website, a centralized resource meant to show people in the bleeding disorders community when diagnosis-specific charitable assistance funds are available. This is not flashy technology, nor should it be treated like some grand...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Notary Journal Offers Streamlined Solutions

Updated Category News Views 108

Transforming Notary Services In the realm of notary services, efficiency and organization are paramount. An inventive spirit from Richmond has stepped forward, seeking to revolutionize the notary journal—a pivotal tool for professionals in this industry. The concept, aptly named the NOTARY JOURNAL, aims to streamline the process of recording signatures and vital...

Continue Reading
Cappfinity's Big Bet: Reshaping Leadership Impact

Updated Category News Views 20

Leadership Reimagined for a Changing World The market's no walk in the park right now, and Cappfinity’s stepping in with its new Leadership Contribution Platform to tackle the very thing that every organization’s biting nails over—leadership. We're talking about a total shift in how leadership’s gauged, understood, and developed. And yep, it’s about time someone...

Continue Reading
Spain Invests €19.6M in Quantix for Cybersecurity Hub

Updated Category News Views 239

Spain Boosts Cybersecurity Innovation with Quantix Investment The Spanish government's latest initiative aims to enhance cybersecurity and microelectronics innovation through an impressive investment of €19.6 million in Quantix. This investment is part of a broader effort to develop a cutting-edge Cybersecurity and Microelectronics Center in a strategic region....

Continue Reading
Innovative Income Strategies with New Simplify ETFs Launch

Updated Category News Views 232

Innovative Income Strategies with New Simplify ETFs Launch In a move designed to empower investors, Simplify Asset Management has introduced two innovative Exchange Traded Funds (ETFs) aimed at delivering capital-efficient exposure to gold and U.S. small-cap equities while generating consistent income. The newly launched funds are the Simplify Gold Strategy PLUS Income...

Continue Reading
California Takes Action Against Exxon Mobil for Plastic Waste

Updated Category News Views 121

California's Bold Move Against Exxon Mobil The state of California has initiated a major lawsuit against Exxon Mobil, one of the world's leading oil companies, accusing it of being complicit in the global plastic waste crisis. This legal action was announced by Attorney General Rob Bonta during an event focused on the necessity of climate action. Details of the Lawsuit...

Continue Reading